The results showed that combination of the two DC vaccines exhibited better efficacy in suppressing tumor growth and prolonging survival than either of the two DC vaccines alone in both ectopic and orthotopic allograft immunocompetent C3H/HeN mouse models of a stable AFP-expressing mouse HCC cell line, Hepa129. This evidence concerns the gene AFP and hepatocellular carcinoma.